Different relative activities of human cell-derived interferon-α subtypes: IFN-α8 has very high antiviral potency

Journal of Interferon and Cytokine Research

Volumn 16, Issue 12, 1996, Pages 1027-1033

  Foster, G R ^a   Rodrigues, O ^a   Ghouze, F ^a   Schulte Frohlinde, E ^a   Testa, D ^b,e   Liao, M J ^b   Stark, G R ^c   Leadbeater, L ^d   Thomas, H C ^a  

^a ST MARY S HOSPITAL   (United Kingdom)

^b Interferon Sciences Inc   (United States)

^c LERNER RESEARCH INSTITUTE   (United States)

^d GLAXOSMITHKLINE   (United Kingdom)

^e AAG Incorporated   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON;

ANTIVIRAL ACTIVITY; ARTICLE; CELLULAR IMMUNITY; CONTROLLED STUDY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN CELL; LEUKOCYTE; LYMPHOBLASTOID CELL; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

EID: 0030467464     PISSN: 10799907     EISSN: None     Source Type: Journal    
DOI: 10.1089/jir.1996.16.1027     Document Type: Article

References (31)

1. PESTKA, S., LANGER, J., ZOON, K., and SAMUEL, C. (1987). Interferons and their actions. Annu. Rev. Biochem. 56, 727-777.
2. DIAZ, M., BOHLANDER, S., and ALLEN, G. (1993). Nomenclature of human interferon genes. J. Interferon Res. 13, 243-247.
3. ALLEN, G. (1994). Analysis of covalent structures of interferon molecular species from human (Namalwa) lymphoblastoid cells. J. Interferon Res. S1, S65.
4. HISCOTT, J., CANTELL, K., and WEISSMAN, D. (1984). A novel class of human type I interferons. Nucleic Acids. Res. 13, 4739-4749.
5. HAUPTMAN, R., and SWEETLY, P. (1985). A novel class of human type I interferons. Nucleic Acids Res. 13, 4739-4749.
6. ADOLF, G. (1990). Monoclonal antibodies and enzyme immunoassays specific for human interferon omega: evidence that interferon omega is a component of human leucocyte interferon. Virology 175, 410-417.
7. WECK, P., APPERSON, S., MAY, L., and STEBBING, N. (1981). Comparison of the antiviral activities of various cloned human interferon alpha subtypes in mammalian cell cultures. J. Gen. Virol. 57, 233-242.
8. PESTKA, S., EVINGER, M., MAEDA, S., REHDER, E., FAMILLETTI, P., and KELDER, B. (1981). Biological properties of natural and recombinant interferons. Tex. Rep. Biol. Med. 1, 31-36.
9. REHBERG, E., KELDER, B., HOAL, E, and PESTKA, S. (1982). Specific molecular activities of recombinant and hybrid leukocyte interferons. J. Biol. Chem. 257, 11497-11502.
10. EVINGER, M., RUBINSTEIN, M., and PESTKA, S. (1981). Antiproliferative and antiviral activities of human leukocyte interferons. Arch. Biochem. Biophys. 210, 319-329.
11. FISH, E., BANERJEE, K., and STEBBING, N. (1983). Human leukocyte interferon subtypes have different antiproliferative and antiviral activities on human cells. Biochem. Biophys. Res. Commun. 112, 537-546.
12. SPERBER, S., GOCKE, D., HABERZETTI, C., KUK, R., SCHWARTZ, B., and PESTKA, S. (1992). Anti-HIV activity of recombinant and hybrid species of interferon alpha. J. Interfon Res. 12, 363-368.
13. SPERBER, S., HUNGER, S., SCHWARTZ, B., and PESTKA, S. (1993). Anti-rhinoviral activity of recombinant and hybrid species of interferon alpha. Antiviral Res. 22, 121-129.
14. EVINGER, M., RUBINSTEIN, M., and PESTKA, S. (1980). Growth inhibitory and antiviral activity of purified leukocyte interferon. Ann. NY Acad. Sci. 350, 399-404.
15. PLATANIAS, L., UDDIN, S., and COLAMONICII, O. (1994). Tyrosine phosphorylation of the a and b subunits of the type I interferon receptor. Interferon β selectively induces phosphorylation of a subunit associated protein. J. Biol. Chem. 269, 17761-17764.
16. ABRAMOVITCH, C., SHULMAN, L., RATOVISKI, E., TOVEY, M., EID, P., and REVEL, M. (1995). Differential tyrosine phosphorylation of the IFNAR chain of the type I interferon receptor and of an EMBO J. 13, 5871-5877.
17. UZE, G., LUTFALLA, G., and MOGENSEN, K. (1995). Alpha and beta interferons and their receptor and their friends and relatives. J. Interferon Cytokine Res. 15, 326.
18. UZE, G., LUTFALLA, G., and GRESSER, I. ( 1990). Genetic transfer of a functional human interferon alpha receptor into mouse cells: cloning and expression of its cDNA. Cell 60, 225-234.
19. DOMANSKJ, P., WITTE, M., KELLUM, M., RUBINSTEIN, M., HACKETT, R., PITHA, P., and COLAMONICII, O. (1995). Cloning and expression of a long form of the beta subunit of the interferon alpha/beta receptor that is required for signaling. J. Biol. Chem. 270, 21606-21611.
20. LUTFALLA, G., HOLLAND, S., CINATO, E., MONNERON, D., REBOUL, J., ROGERS, N. et al. (1995). Mutant U5A cells are complemented by an interferon alpha/beta receptor subunit generated by alternative processing of a new member of a cytokine receptor gene cluster. EMBO 14, 5100-5108.
21. PELLEGRINI, S., JOHN, J., SHEARER, M., KERR, I., and STARK, G. (1989). Use of a selectable marker regulated by alpha interferon to obtain mutations in the signalling pathway. Mol. Cell. Biol. 9, 4605-4612.
22. PAYNE, M., and LEADBEATER, L. (1990). The composition of lymphoblastoid interferon (Wellferon). J. Interferon Res. 11, S263.
23. RUBINSTEIN, M., LEVY, W., MOSCHERA, J., LAI, C, HERSHBERG, R., BARTLETT, R., et al. (1981). Human leukocyte interferon: isolation and characterisation of several molecular forms. Arch. Biochem. Biophys. 210, 307-318.
24. FAN, S., SKILLMAN, D., LIAO, M., TESTA, D., and MELTZER, M. (1993). Increased efficacy of human natural interferon alpha versus recombinant alpha 2 for inhibition of HIV-1 replication in human monocytes. AIDS Res. Hum. Retrovir. 9, 1115-1122.
25. ZOON, K., MILLER, D., BEKISZ, J., ENTERLINE, J., NGUYEN, N., and HU, R. (1992). Purification and characterization of multiple components of human lymphoblastoid interferon alpha. J. Biol. Chem. 267, 15210-15216.
26. MULLER, M., BRISCOE, J., LAXTON, C., GUSCHIN, D., ZIEMIECKIL, A., SILVENNOINEN, M., HARPUR, A., et al. (1993). The protein tyrosine kinase JAK1 complements defects in interferon-α/β and gamma signal transduction. Nature 366, 129-135.
27. MULLER, M., IBELGAUFTS, H., and KERRI. (1994). Interferon response pathways - a paradigm for cytokine signalling? J. Viral. Hep. 1, 87-103.
28. DARNELL, J., KERR, I., and STARK, G. (1994). Jak STAT pathoways and transcriptional activation in response to interferons and other extracellular signalling proteins. Science 264, 1415-1421.
29. ORTALDO, J., HERBERMANN, R., HARVEY, C., OSHEROFF, B., PAN, K., KELDER, K., et al. (1984). A species of human interferon that lacks the ability to boost natural killer cell activity. Proc. Natl. Acad. Sci. USA 81, 4926-4929.
30. COOK, J.R., CLEARY, C., IZOTOVA, L., and PESTKA, S. (1995). Ligand specific interactions of a splice variant form of the human interferon alpha receptor. J. Interferon Cytokine Res. 15, S97.
31. TAKA, T., and KISHIMOTO, T. (1990). Cytokine receptors and signal transduction. Cell 61, 203-212.